Home  >  News
Eppen_CellXpert_Mar2026
you can get e-magazine links on WhatsApp. Click here
News
China NMPA approves Harbour BioMed and Kelun-Biotech’s IND application for HBM7575/SKB575 to treat atopic dermatitis  March 10, 2026
IDEAYA Biosciences begins patient dosing in phase 1 trial of IDE892, a potential best-in-class PRMT5 inhibitor for MTAP-deleted solid tumours  March 10, 2026
Fujitsu and DT-Axis collaborate to advance digital health  March 10, 2026
Merck engages Young Minds at IISc Open Day 2026 with Interactive Science Activities  March 10, 2026
METI & TSE select Chugai for the “2026 KENKO Investment for Health” for the third consecutive year  March 10, 2026
Galderma introduces Cetaphil AM/PM Antioxidant Serums, a new science-driven defense and recovery system for sensitive skin  March 10, 2026
Heidelberg Pharma and HealthCare Royalty amend to existing royalty agreement and the participation of Soleus Capital  March 10, 2026
Haryana FDA launches massive crackdown, 124 medical shops raided in strategic strike  March 10, 2026
Roche’s phase III persevERA Breast Cancer study of giredestrant in combo with palbociclib ER-positive advanced breast cancer fails to meet its primary objective  March 10, 2026
US FDA accepts and grants priority review status to AstraZeneca and Daiichi Sankyo’s sBLA for Enhertu to treat adult patients with HER2-positive early breast cancer  March 10, 2026
GSK and Alfasigma ink agreement on worldwide rights for linerixibat, an IBAT inhibitor for cholestatic pruritus in primary biliary cholangitis  March 10, 2026
Karnataka govt expands scope of severe acute malnutrition related procedures  March 10, 2026
 Back
 
Propak_Asia_2026
CP_CPHI_Korea2026
ChemExpo_India_2026
PharmaTech_expo_Chandigarh2026
ASIA_PHARMA_EXPO_2026
CPHI_Japan26
Ana_Lab_India_2026
PharmaCore_India_2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram